Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,138,330 papers from all fields of science
Search
Sign In
Create Free Account
oxaliplatin
Known as:
1,2-diaminocyclohexane platinum oxalate
, oxaliplatinum
, trans-l diaminocyclohexane oxalatoplatinum
Expand
An organoplatinum complex in which the platinum atom is complexed with 1,2-diaminocyclohexane (DACH) and with an oxalate ligand as a 'leaving group…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
33 relations
10 ML oxaliplatin 5 MG/ML Injection
10 ML oxaliplatin 5 MG/ML Injection [Eloxatin]
Apoptosis
CAPOX Regimen
Expand
Narrower (2)
ACT 078
Eloxatin
Broader (2)
Antineoplastic Agents
Organoplatinum Compounds
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Oncotype DX(®) colon cancer assay for prediction of recurrence risk in patients with stage II and III colon cancer: A review of the evidence.
Y. Nancy You
,
Rudolph B. Rustin
,
James D. Sullivan
Surgical oncology
2015
Corpus ID: 43690608
Highly Cited
2014
Highly Cited
2014
Photosensitive Pt(IV)-azide prodrug-loaded nanoparticles exhibit controlled drug release and enhanced efficacy in vivo.
Haihua Xiao
,
G. Noble
,
+4 authors
Basar Bilgicer
Journal of Controlled Release
2014
Corpus ID: 19386347
Highly Cited
2008
Highly Cited
2008
Effect of preoperative chemotherapy on liver resection for colorectal liver metastases.
Naimish Mehta
,
R. Ravikumar
,
+6 authors
Darius F. Mirza
European Journal of Surgical Oncology
2008
Corpus ID: 24467731
Review
2006
Review
2006
Salvage bevacizumab (rhuMAB VEGF)-based therapy after multiple prior cytotoxic regimens in advanced refractory epithelial ovarian cancer
B. Monk
,
E. Han
,
Carol A. Josephs-Cowan
,
Gordon Pugmire
,
R. Burger
2006
Corpus ID: 73295685
Highly Cited
2005
Highly Cited
2005
A phase III trial comparing FULV to FULV + oxaliplatin in stage II or III carcinoma of the colon: Survival results of NSABP Protocol C-07
N. Wolmark
,
S. Wieand
,
P. Kuebler
,
L. Colangelo
,
M. O’connell
,
G. Yothers
2005
Corpus ID: 74490104
LBA4005 Background: We previously reported that FULV + oxaliplatin (FLOX) significantly prolonged 3-year disease-free survival…
Expand
Highly Cited
2005
Highly Cited
2005
Measurement of genotoxic air pollutant exposures in street vendors and school children in and near Bangkok.
M. Ruchirawat
,
P. Navasumrit
,
Daam Settachan
,
Jantamas Tuntaviroon
,
Nantaporn Buthbumrung
,
S. Sharma
Toxicology and Applied Pharmacology
2005
Corpus ID: 41199853
Highly Cited
2004
Highly Cited
2004
Comparison of analyses of urinary 8-hydroxy-2'-deoxyguanosine by isotope-dilution liquid chromatography with electrospray tandem mass spectrometry and by enzyme-linked immunosorbent assay.
Chiung-Wen Hu
,
Ming-Tsang Wu
,
+4 authors
Kuen-Yuh Wu
Rapid Communications in Mass Spectrometry
2004
Corpus ID: 20983711
A highly sensitive and selective method, using isotope-dilution liquid chromatography with tandem mass spectrometry (LC/MS/MS…
Expand
Review
2004
Review
2004
Multiple management modalities in esophageal cancer: combined modality management approaches.
M. Koshy
,
Natia Esiashvilli
,
J. Landry
,
Charles R. Thomas
,
R. Matthews
The Oncologist
2004
Corpus ID: 42905756
The overall success rate nationally in treating esophageal carcinomas remains poor, with over 90% of patients succumbing to the…
Expand
Highly Cited
2001
Highly Cited
2001
Achiral tetrahydrosalen ligands for the synthesis of C(2)-symmetric titanium complexes: a structure and diastereoselectivity study.
Jaume Balsells
,
Patrick J. Carroll
,
Patrick J Walsh
Inorganic Chemistry
2001
Corpus ID: 35451767
Achiral tetrahydrosalen ligands have been employed in the synthesis of chiral C(2)-symmetric titanium complexes. When combined…
Expand
Highly Cited
1999
Highly Cited
1999
Cellular pharmacology of the combination of the DNA topoisomerase I inhibitor SN-38 and the diaminocyclohexane platinum derivative oxaliplatin.
N. Zeghari-Squalli
,
Eric Raymond
,
Esteban Cvitkovic
,
François Goldwasser
Clinical Cancer Research
1999
Corpus ID: 11917062
CPT-11, a DNA topoisomerase I inhibitor, and oxaliplatin, a diaminocyclohexane platinum derivative, are cytotoxic agents that…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE